Germline testing for breast cancer patients in England: illogical to prioritise grade 1 breast cancer aged 30-39 over grade 3 aged 40-49 years?

IF 3.5 2区医学 Q2 GENETICS & HEREDITY

Journal of Medical Genetics Pub Date : 2024-09-24 DOI:10.1136/jmg-2024-110183

D Gareth Evans, Sacha J Howell, George J Burghel, Claire Forde, Fiona Lalloo, Miriam J Smith, Anthony Howell, Ashu Gandhi, Emma Roisin Woodward

引用次数: 0

查看原文本刊更多论文

英格兰乳腺癌患者的基因检测：30-39 岁的 1 级乳腺癌优先于 40-49 岁的 3 级乳腺癌不合逻辑？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Medical Genetics 医学-遗传学

CiteScore

7.60

自引率

2.50%

发文量

审稿时长

4-8 weeks

期刊介绍： Journal of Medical Genetics is a leading international peer-reviewed journal covering original research in human genetics, including reviews of and opinion on the latest developments. Articles cover the molecular basis of human disease including germline cancer genetics, clinical manifestations of genetic disorders, applications of molecular genetics to medical practice and the systematic evaluation of such applications worldwide.